相关实验视频

Updated: Feb 21, 2026

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

通过CRISPR-Cas9基编辑消除PKCα酸化挽救心力衰竭

Tomonori Tadokoro^1,2, Hui Li^1,2, Peiheng Gan^1,2,3

¹Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas. (T.T., H.L., P.G., Z.X., W.T., D.A., E.S.-O., J.R.M., N.L., E.N.O.).

Circulation research

|February 20, 2026

概括

通过向三素497 (T497) 酸化,对蛋白质激酶Cαα (PKCα) 进行基因编辑,为心力衰竭提供了一种新的治疗策略. 这种方法可以防止心脏功能障碍和重塑,显示出治疗人类心脏病的前景.

科学领域:

心血管研究研究心血管研究
分子心脏病学分子心脏病学
基因治疗基因治疗

背景情况:

全球心力衰竭患病率不断增加,需要新的治疗策略.
蛋白激酶Cααα (PKCα) 涉及到心力衰竭的发病.
酸化PKCα到氨酸497 (T497) 对于其激活和稳定至关重要.

研究的目的:

调查心力衰竭中抑制PKCα T497酸化的治疗潜力.
评估CRISPR-Cas9腺因基编辑在体内和体外引入T497A突变方面的有效性.

主要方法:

使用CRISPR-Cas9.9生成生殖基因抗PKCα (T497A) 突变小鼠.
在野生类型小鼠中通过腺相关病毒9递送基因编辑器进行产后基因组编辑,以引入T497A替代.
使用横向大动脉收缩建模心力衰竭,其次是心脏功能,组织学和转录学分析.
编辑人类诱导的多能干细胞,以引入PRKCA T497A突变,用于体外研究心肌细胞功能和平衡.

主要成果:

T497A突变导致PKCα蛋白降解,并阻止其激活.
抗PKCα素的小鼠得到了保护,免受横向大动脉收缩引起的心脏缩,纤维化和功能衰退.
在体内基础编辑实现了类似的心脏保护作用,在体内研究表明,编辑心肌细胞受到AngII诱导损伤的保护.

结论:

消除PKCα T497酸化可以显著地保护心脏.
针对PRKCA T497A的CRISPR-Cas9腺基编辑是治疗心力衰竭的可行策略.
这种基因编辑方法具有作为人类心脏病治疗策略的潜力.

关键词:

ангиотензин II 的使用基因编辑基因编辑心脏衰竭是因为心脏衰竭.鼠标鼠标鼠标鼠标蛋白质激酶Cααα酶是什么

更多相关视频

CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts

CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts

Published on: September 13, 2022

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...